Page 1

Lipid regulators market Lipid regulators market: In 2015, the market for lipid regulators amounted to $XX billion and the market size is expected to expand to $XX billion by 2021 with CAGR at XX%. Lipid regulators or lipid-regulating medicines are used to treat complications of dyslipidemia, cardiovascular issues, osteoporosis and post-menopause. Thats why these lipid regulators are among the most prescribed drugs in the class. A study shows that for these statins over 255.4 million prescriptions are filled every year. The statin market is being energized by lipid regulators including a complete spectrum of statin and non-statin products.

Global market segmentation for lipid regulators is predominantly based on type’s statins and non-statins and geographic regions. Statins also include sub-segments such as branded statins, combinations of statins and generic statins, whereas non-statins are sub-divided into derivatives of fibric acid, bile acid sequestrants, derivatives of nicotinic acid and other new products. North America is leading the global lipid regulator market followed by Europe. However, emerging nations such as India and China are contributing to these markets profits by placing Asia Pacific in the list of top areas holding greater market share for lipid regulators. This can be due to rising disease incidences and rising therapeutic demand. Abbott Laboratories, Andrx Corporation, Astrazeneca, Atellas Pharma, Inc., Bristol-Myers Squibb, Pfizer, Novartis, Merck, Teva Pharmaceuticals and Bentley Pharmaceuticals, among others, are main competitors for this industry.

Get a Free Sample Copy of this Report @ Drivers: Increasingly aggressive rules are boosting the statin market. Other factors driving this market are the growing amount of therapy population, aging population, demand for advancing therapy, enhanced patient compliance and public support. Opportunity: Expanding population base, increased prevalence of diseases, large patient population and upsurge in disposable income of the population are some of the drivers that shove the usage of lipid regulators, and help in development of the market. Restraints: Lipid Regulators low knowledge primarily restricts the potential of the worldwide economy. Furthermore, the failure of physicians to adhere to the National Cholesterol Education Program NCEP, the introduction of combination drugs and the introduction of generic low price. Get More Information about this Report and TOC @ This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

TABLE OF CONTENT: CHAPTER 1 INTRODUCTION 1.1. Market Definition 1.2. Executive Summary 1.3. The Scope of the Study CHAPTER 2 RESEARCH METHODOLOGY 2.1. Secondary Research 2.2. Primary Research 2.3. Analytic Tools and Model 2.4. Economic Indicator 2.4.1. Base Year, Base Currency, Forecasting Period 2.5. Expert Validation 2.6. Study Timeline CHAPTER 3 MARKET ANALYSIS 3.1. Industry Value Chain Analysis 3.2. Porters Five Force Analysis 3.2.1. Bargaining Power of Buyers 3.2.2. Bargaining Power of Suppliers 3.2.3. Threats of Substitutes 3.2.4. Threats of New Entrants 3.2.5. Degree of Competition 3.3. PESTLE Analysis 3.3.1. Political 3.3.2. Economical 3.3.3. Social 3.3.4. Technological

3.3.5. Legal 3.3.6. Environmental 3.4. SWOT Analysis 3.4.1. Strengths 3.4.2. Weakness 3.4.3. Opportunities 3.4.4. Threats 3.5. Y-O-Y Analysis CHAPTER 4 MARKET DYNAMICS 4.1. Market Drivers 4.1.1. Increasing aging population 4.1.2. Rising aggressive guidelines 4.1.3. Enhancing the demand for advancing therapeutics 4.1.4. Growing number of treatment population 4.1.5. Government support 4.1.6. Improvement in patient compliance 4.2. Market Restraints 4.2.1. Establishment of combination drugs 4.2.2. Low awareness of lipid regulators 4.2.3. Introduction of low cost generics 4.2.4. Non-adherence to NCEP guidelines by physicians 4.3. Market Opportunities 4.4. Market Challenges Enquire Now‌ @ CHAPTER 5 GLOBAL LIPID REGULATORS MARKET – BY TYPE 5.1. Statins 5.1.1. Statin combinations 5.1.2. Branded statins 5.1.3. Generic statins 5.1.4. Others 5.2. Non-statins 5.2.1. Nicotinic acid derivatives 5.2.2. Bile-acid sequestrants 5.2.3. Fibric-acid derivatives 5.2.4. Others CHAPTER 6 GLOBAL LIPID REGULATORS MARKET - BY GEOGRAPHY 6.1. Introduction

6.2. North America 6.2.1. U.S. 6.2.2. Canada 6.2.3. Mexico 6.2.4. Costa Rica 6.3. South America 6.3.1. Brazil 6.3.2. Argentina 6.3.3. Chile 6.3.4. Columbia 6.3.5. Others 6.4. Europe 6.4.1. U.K. 6.4.2. Germany 6.4.3. France 6.4.4. Italy 6.4.5. Spain 6.4.6. Russia 6.4.7. Netherlands 6.4.8. Switzerland 6.4.9. Poland 6.4.10. Others 6.5. Asia Pacific 6.5.1. China 6.5.2. Japan 6.5.3. India 6.5.4. South Korea 6.5.5. Australia & New Zealand 6.5.6. Malaysia 6.5.7. Singapore 6.5.8. Others 6.6. Middle East & Africa 6.6.1. UAE 6.6.2. Saudi Arabia 6.6.3. Iran 6.6.4. Iraq 6.6.5. Qatar 6.6.6. South Africa

6.6.7. Algeria 6.6.8. Morocco 6.6.9. Nigeria 6.6.10. Egypt 6.6.11. Others CHAPTER 7 GLOBAL LIPID REGULATORSMARKET – COMPANY PROFILES 7.1. AstraZeneca plc 7.2. Bristol-Myers Squibb Company 7.3. Andrx Corporation 7.4. Merck & Co., Inc. 7.5. Abbott Laboratories 7.6. Novartis International AG 7.7. Atellas Pharma, Inc. 7.8. Pfizer Inc., 7.9. Bentley Pharmaceuticals 7.10. Teva Pharmaceuticals CHAPTER 8 GLOBAL LIPID REGULATORSMARKET - COMPETITIVE LANDSCAPE 8.1. Market Share Analysis 8.2. Strategies adopted by top companies 8.3. Mergers, Acquisitions, Collaborations & Agreements CHAPTER 9 MARKET INSIGHTS 9.1. Industry Experts Insights 9.2. Analysts Opinions 9.3. Investment Opportunities CHAPTER 10 APPENDIXES 10.1. List of Tables 10.2. List of Figures About Us: Planet Market Reports gives statistical surveying reports to businesses, people and associations with a goal of helping them in their decision-making process. We have a huge database of market research reports & company profiles across the globe. We offer premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Planet Market Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, & industry experts which provide you deeper penetration of market research industry ensuring you will receive the most reliable and up to date research data available. Name: Jennifer Daniel Email-Id: US: +1-716-2260907 UK: +447441952057 Organization: Planet Market Reports

Profile for william joe

Lipid regulators market analysis and forecast  

In 2015, the market for lipid regulators amounted to $XX billion and the market size is expected to expand to $XX billion by 2021 with CAGR...

Lipid regulators market analysis and forecast  

In 2015, the market for lipid regulators amounted to $XX billion and the market size is expected to expand to $XX billion by 2021 with CAGR...

Profile for willjo936